NextFin News - GMR Solutions Inc., the emergency medical services giant backed by KKR & Co., is targeting a capital raise of up to $797.9 million in its U.S. initial public offering, marking a significant test for the healthcare services sector in a revitalized primary market. The company, widely known as Global Medical Response, disclosed in a regulatory filing on Monday that it plans to sell 31.3 million shares priced between $23 and $25.50 each. At the top end of that range, the Lewisville, Texas-based firm would command a market valuation of approximately $5.2 billion.
The offering represents a pivotal exit path for KKR, which formed the entity in 2018 through the merger of Air Medical Group Holdings and American Medical Response. Following the IPO, GMR will remain a "controlled company," with KKR retaining a majority of the voting power. This structure is common among private equity-backed listings but often draws scrutiny from institutional investors concerned about minority shareholder protections and the long-term alignment of the private equity sponsor’s exit strategy with the company’s operational stability.
Financial performance data included in the filing shows GMR reported a net income of $206.2 million on revenue of $5.74 billion for the fiscal year ending December 31, 2025. While the return to profitability is a positive signal, some analysts have raised concerns regarding the company’s balance sheet. According to a report from Seeking Alpha, GMR continues to grapple with a high debt load and contracting revenue in certain segments, factors that could weigh on its valuation multiple compared to leaner healthcare peers. The analyst noted that while GMR maintains a dominant market position, serving over 60% of the U.S. population across 1,400 counties, its capital-intensive model requires consistent cash flow to service its obligations.
The timing of the IPO coincides with a broader recovery in the U.S. listing environment under the administration of U.S. President Trump, where regulatory clarity and a focus on domestic infrastructure have encouraged large-scale industrial and service providers to tap public markets. GMR’s scale is formidable; the company manages roughly 5.5 million annual patient encounters and employs more than 24,000 clinicians. However, the air ambulance industry has faced regulatory headwinds in recent years, particularly regarding "surprise billing" legislation, which has forced providers to renegotiate reimbursement rates with insurers.
Goldman Sachs, Barclays, and JPMorgan Chase are leading the underwriting syndicate for the offering. The company intends to list its shares on the New York Stock Exchange under the ticker symbol GMRS. Proceeds from the sale are expected to be used primarily for debt repayment and general corporate purposes, a move that would address the leverage concerns cited by market skeptics. Whether investors will look past the debt to focus on GMR’s essential role in the U.S. healthcare safety net will be the defining question when the stock begins trading later this week.
Explore more exclusive insights at nextfin.ai.
